Neutrophil-to-Lymphocyte and Platelet-to-lymphocyte Ratios as a Predictor Factors for Chronic Kidney Disease Progression

ConditionCKD

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-65

SponsorAssiut University

About this trial

In this study, we aim to investigate whether NLR and PLR levels are associated with decline of kidney function in patients with CKD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

200 Patients diagnosed with CKD and their age range between 18-65 years old who will be admitted at AUH.

Disqualifiers

Pediatric patients aged below< 18 or elderly patients aged above 65.

Pregnant females.

Patients with Diabetes Mellitus.

Acute kidney injury (AKI).

Trial population

Prevalence of Chronic Kidney disease (CKD) in 2017 was 7.1 million individuals globally and in Egypt was 106 patients per 1000 population estimated by (GBD) the Global Burden of Disease. In September 2021, about 10% of adult population is estimated to have CKD in the world, but the prevalence is higher in Egypt accounted for about 15-20% of adults.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

Correlation between NLR, PLR and severity of CKD.

Time frame

Baseline

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: